Al-Lawati J A, Mohammed A J
Non-Communicable Diseases Section and Health Affairs, Ministry of Health, Muscat, Oman.
Ann Saudi Med. 2000 Jan;20(1):12-5. doi: 10.5144/0256-4947.2000.12.
Diabetes mellitus (DM) is a major public health problem in Oman. We evaluated the impact of the revised diagnostic criteria for DM adopted by the American Diabetes Association (ADA) on the prevalence of diabetes and impaired glucose tolerance (IGT), and on the classification of individuals among the Omani population.
We used the dataset of the National Diabetes Survey, conducted in 1991 and involving 4682 subjects who did not have any missing data on fasting and 2-hour glucose. The subjects comprised 2002 males and 2680 females aged 20 years or above. Data were analyzed using the ADA criteria (diabetes as fasting plasma glucose [FPG] > or =7 mmol/L, impaired fasting glucose [IFG] as FPG > or =6.1 mmol/L and <7 mmol/L), and compared these with the World Health Organization (WHO) criteria (diabetes as FPG > or =7.8 mmol/L and/or 2-hour post-glucose load > or =11.1 mmol/L, IGT as FPG <7.8 mmol/L, and 2-hour post-load 7.8-11.1 mmol/L).
Applying the ADA criteria on the Omani population resulted in an overall reduction of diabetes prevalence by 2.2% (95% confidence interval [CI] 1.6% to 2.8%), and a 4.8% reduction of IGT (95% CI 3.8% to 5.8%). Over 29% of diabetics classified by the WHO criteria were reclassified as being normal or having IFG by the ADA criteria. Around 3.6% of those who were normoglycemic by the WHO criteria were classified as having diabetes or IFG by the ADA criteria. In all but one region of Oman, the prevalence of diabetes and IFG using the ADA criteria was lower compared to the prevalence using the WHO criteria. Gender, age and body mass index did not seem to pose an increased risk to the probability of being diagnosed by one criteria or the other or both together.
The adoption of the ADA criteria in Oman will significantly reduce the prevalence of diabetes and IGT. In addition, the glycemic status of a substantial number of individuals will be changed from normal to either being diabetic or having IGT.
糖尿病(DM)是阿曼的一个主要公共卫生问题。我们评估了美国糖尿病协会(ADA)采用的糖尿病修订诊断标准对糖尿病患病率、糖耐量受损(IGT)以及阿曼人群个体分类的影响。
我们使用了1991年进行的全国糖尿病调查数据集,该数据集涉及4682名在空腹和2小时血糖方面无任何缺失数据的受试者。受试者包括2002名男性和2680名年龄在20岁及以上的女性。使用ADA标准(糖尿病定义为空腹血糖[FPG]≥7 mmol/L,空腹血糖受损[IFG]定义为FPG≥6.1 mmol/L且<7 mmol/L)对数据进行分析,并将其与世界卫生组织(WHO)标准(糖尿病定义为FPG≥7.8 mmol/L和/或葡萄糖负荷后2小时≥11.1 mmol/L,IGT定义为FPG<7.8 mmol/L且负荷后2小时为7.8 - 11.1 mmol/L)进行比较。
对阿曼人群应用ADA标准导致糖尿病总体患病率降低2.2%(95%置信区间[CI]为1.6%至2.8%),IGT患病率降低4.8%(95% CI为3.8%至5.8%)。根据WHO标准分类的糖尿病患者中,超过29%被ADA标准重新分类为正常或患有IFG。根据WHO标准血糖正常的人群中,约3.6%被ADA标准分类为患有糖尿病或IFG。在阿曼除一个地区外的所有地区中,使用ADA标准的糖尿病和IFG患病率低于使用WHO标准的患病率。性别、年龄和体重指数似乎并未增加被一种标准或两种标准同时诊断的概率。
在阿曼采用ADA标准将显著降低糖尿病和IGT的患病率。此外,相当一部分个体的血糖状态将从正常变为患有糖尿病或IGT。